Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

The renal type H+/peptide symporter PEPT2: structure-affinity relationships.

A Biegel1, I Knütter, B Hartrodt

  • 1Institute of Biochemistry, Department of Biochemistry/Biotechnology, Martin-Luther-University Halle-Wittenberg, Halle, Germany.

Amino Acids
|July 27, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Energy-based therapies for vulvar lichen sclerosus: A systematic review of randomized controlled trials.

Maturitas·2026
Same author

From consultation to choice: gynecologic cancer patients' perspectives on shared decision making in clinical practice - findings from a cross-sectional observational qualitative interview study.

BMC medical ethics·2026
Same author

Plasma metabolomic profiles reveal sex-specific response to an oral glucose tolerance test in late middle-aged adults.

Mechanisms of ageing and development·2025
Same author

Effects of food matrix on the prebiotic efficacy of inulin-type fructans: a randomised trial.

Beneficial microbes·2024
Same author

Quality of life in menopausal women in the workplace - a systematic review.

Climacteric : the journal of the International Menopause Society·2023
Same author

Short chain fatty acids in human gut and metabolic health.

Beneficial microbes·2020

The peptide transporter PEPT2, found in organs like the kidney and lung, facilitates the uptake of peptide-like drugs. Understanding PEPT2

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Biochemistry

Background:

  • The H(+)/peptide cotransporter PEPT2 is expressed in key organs including the kidney, lung, brain, mammary gland, and eye.
  • PEPT2 transports dipeptides, tripeptides, and peptidomimetics like beta-lactam antibiotics.
  • Its presence in the bronchial epithelium suggests potential for aerosol drug delivery.

Purpose of the Study:

  • To compile and compare substrate affinity data for PEPT2 across various mammalian tissues and expression systems.
  • To analyze the structural basis for substrate recognition by PEPT2 in comparison to PEPT1.
  • To highlight the role of PEPT2 in the disposition and half-life of peptide-like drugs.

Main Methods:

  • Literature review compiling affinity constants for 352 compounds.

Related Experiment Videos

  • Comparative analysis of PEPT2 and PEPT1 substrate specificity.
  • Data collation from diverse mammalian tissues and in vitro expression systems.

    • Main Results:

    • A comprehensive dataset of 352 compounds and their affinity constants for PEPT2 was assembled.
    • Comparisons were made between PEPT2 and PEPT1 substrate affinities where data overlapped.
    • Tissue and system-specific variations in PEPT2 substrate affinity were noted.

    Conclusions:

    • PEPT2 plays a crucial role in the pharmacokinetics of peptide-like drugs, particularly in the kidney and brain.
    • Aerosolized peptide-drug delivery via PEPT2 presents a promising therapeutic avenue for pulmonary and systemic diseases.
    • Detailed substrate affinity data provides a foundation for designing novel peptide-based therapeutics targeting PEPT2.